Emily M. King
- Genetics top 10%
- Virus-based gene therapy research 3
-
- RNA modifications and cancer 2
- CRISPR and Genetic Engineering 2
- RNA Interference and Gene Delivery 1
-
- Viral Infections and Immunology Research 1
-
- T-cell and Retrovirus Studies 2
-
- Cancer-related molecular mechanisms research 1
-
- CAR-T cell therapy research 1
- Co-authors
- Simon YeKim A. LagerborgMohammadsharif TabebordbarAlexandra C. StantonPardis C. SabetiAmy J. WagersBehzad MoghadaszadehJeffrey J. Widrick
- Partner nations
- United States
In The Last Decade
Emily M. King
5 papers receiving 359 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Genetics 191
- Aging 11
- Business and International Management 9
- Molecular Biology 304
- Cardiology and Cardiovascular Medicine 61
Countries citing papers authored by Emily M. King
This map shows the geographic impact of Emily M. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily M. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily M. King more than expected).
Fields of papers citing papers by Emily M. King
This network shows the impact of papers produced by Emily M. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily M. King. The network helps show where Emily M. King may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily M. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 33 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 34 | |
| 6 | Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across speciesbreakdown → | 2021 | 292 |
About Emily M. King
Emily M. King is a scholar working on Genetics, Immunology and Molecular Biology, having authored 6 papers that have together received 363 indexed citations. Recurring topics across this work include Virus-based gene therapy research (3 papers), RNA modifications and cancer (2 papers), T-cell and Retrovirus Studies (2 papers), CRISPR and Genetic Engineering (2 papers), RNA Interference and Gene Delivery (1 paper), Viral Infections and Immunology Research (1 paper), Cancer-related molecular mechanisms research (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Genetics (191 citations), Aging (11 citations) and Business and International Management (9 citations). Emily M. King has collaborated with scholars based in United States. Frequent co-authors include Simon Ye, Kim A. Lagerborg, Mohammadsharif Tabebordbar, Alexandra C. Stanton, Pardis C. Sabeti, Amy J. Wagers, Behzad Moghadaszadeh, Jeffrey J. Widrick, Kathleen A. Messemer and Naftali Horwitz. Their work appears in journals such as Cell, Nature Biotechnology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.